Alvogen is voluntarily recalling two lots of Fentanyl Transdermal 12 mcg/h Patches distributed starting on April 19, 2019. The Food and Drug Administration (FDA) classified this recall as a Class I Recall on May 15, 2019.

The maker is recalling Fentanyl 12 mcg/h patches because they are mislabeled and instead contain the 50 mcg/h dose. To date, no harmful side effects have been reported due to this recall

We want you to get the information you need to take care of your health. Please visit FDA Safety Recall for more information. You can also call the FDA toll free at 1-888-INFO-FDA (1-888-463-6332) (TTY 711 ) or the Horizon NJ Health Pharmacy Help Desk at 1-800-682-9094 x81016 (TTY 711 ).